MicroRNA-34a: the bad guy in age-related vascular diseases

被引:63
|
作者
Raucci, Angela [1 ]
Macri, Federica [1 ]
Castiglione, Stefania [1 ]
Badi, Ileana [1 ,3 ]
Vinci, Maria Cristina [2 ]
Zuccolo, Estella [1 ]
机构
[1] Ctr Cardiol Monzino IRCCS, Expt Cardiooncol & Cardiovasc Aging Unit, Via C Parea 4, I-20138 Milan, Italy
[2] Ctr Cardiol Monzino IRCCS, Unit Vasc Biol & Regenerat Med, Milan, Italy
[3] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England
关键词
Senescence; Inflammaging; microRNA; Vascular calcification; Atherosclerosis; Diabetes; SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY-DISEASE; MIR-34A EXPRESSION; TUMOR-SUPPRESSOR; REPLICATIVE SENESCENCE; PULMONARY-HYPERTENSION; ELEVATED MICRORNA-34A; EPIGENETIC REGULATION; DEPENDENT REGULATION; MONONUCLEAR-CELLS;
D O I
10.1007/s00018-021-03979-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The age-related vasculature alteration is the prominent risk factor for vascular diseases (VD), namely, atherosclerosis, abdominal aortic aneurysm, vascular calcification (VC) and pulmonary arterial hypertension (PAH). The chronic sterile low-grade inflammation state, alias inflammaging, characterizes elderly people and participates in VD development. MicroRNA34-a (miR-34a) is emerging as an important mediator of inflammaging and VD. miR-34a increases with aging in vessels and induces senescence and the acquisition of the senescence-associated secretory phenotype (SASP) in vascular smooth muscle (VSMCs) and endothelial (ECs) cells. Similarly, other VD risk factors, including dyslipidemia, hyperglycemia and hypertension, modify miR-34a expression to promote vascular senescence and inflammation. miR-34a upregulation causes endothelial dysfunction by affecting ECs nitric oxide bioavailability, adhesion molecules expression and inflammatory cells recruitment. miR-34a-induced senescence facilitates VSMCs osteoblastic switch and VC development in hyperphosphatemia conditions. Conversely, atherogenic and hypoxic stimuli downregulate miR-34a levels and promote VSMCs proliferation and migration during atherosclerosis and PAH. MiR34a genetic ablation or miR-34a inhibition by anti-miR-34a molecules in different experimental models of VD reduce vascular inflammation, senescence and apoptosis through sirtuin 1 Notch1, and B-cell lymphoma 2 modulation. Notably, pleiotropic drugs, like statins, liraglutide and metformin, affect miR-34a expression. Finally, human studies report that miR-34a levels associate to atherosclerosis and diabetes and correlate with inflammatory factors during aging. Herein, we comprehensively review the current knowledge about miR-34a-dependent molecular and cellular mechanisms activated by VD risk factors and highlight the diagnostic and therapeutic potential of modulating its expression in order to reduce inflammaging and VD burn and extend healthy lifespan.
引用
收藏
页码:7355 / 7378
页数:24
相关论文
共 50 条
  • [1] MicroRNA-34a: the bad guy in age-related vascular diseases
    Angela Raucci
    Federica Macrì
    Stefania Castiglione
    Ileana Badi
    Maria Cristina Vinci
    Estella Zuccolo
    Cellular and Molecular Life Sciences, 2021, 78 : 7355 - 7378
  • [2] Correlation between microRNA-34a levels and lens opacity severity in age-related cataracts
    K-H Chien
    S-J Chen
    J-H Liu
    H-M Chang
    L-C Woung
    C-M Liang
    J-T Chen
    T-J Lin
    S-H Chiou
    C-H Peng
    Eye, 2013, 27 : 883 - 888
  • [3] Correlation between microRNA-34a levels and lens opacity severity in age-related cataracts
    Chien, K-H
    Chen, S-J
    Liu, J-H
    Chang, H-M
    Woung, L-C
    Liang, C-M
    Chen, J-T
    Lin, T-J
    Chiou, S-H
    Peng, C-H
    EYE, 2013, 27 (07) : 883 - 888
  • [4] microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
    de Lucia, Claudio
    Komici, Klara
    Borghetti, Giulia
    Femminella, Grazia Daniela
    Bencivenga, Leonardo
    Cannavo, Alessandro
    Corbi, Graziamaria
    Ferrara, Nicola
    Houser, Steven R.
    Koch, Walter J.
    Rengo, Giuseppe
    FRONTIERS IN MEDICINE, 2017, 4
  • [5] MicroRNA-34a and vascular senescence in diabetes
    Thounaojam, Menaka C.
    Bartoli, Manuela
    AGING-US, 2019, 11 (24): : 11799 - 11800
  • [6] Stem Cell-derived Exosomal MicroRNA as Therapy for Vascular Age-related Diseases
    Ren, Hang
    Guo, Ziyuan
    Liu, Yang
    Song, Chunli
    AGING AND DISEASE, 2022, 13 (03): : 852 - 867
  • [7] Epigenetic Regulation of Vascular Aging and Age-Related Vascular Diseases
    Ding, Yang-Nan
    Tang, Xiaoqiang
    Chen, Hou-Zao
    Liu, De-Pei
    AGING AND AGING-RELATED DISEASES: MECHANISMS AND INTERVENTIONS, 2018, 1086 : 55 - 75
  • [8] Vascular smooth muscle cell senescence and age-related diseases: State of the art
    Chi, Chen
    Li, Dong-Jie
    Jiang, Yu-Jie
    Tong, Jie
    Fu, Hui
    Wu, Yi-Hang
    Shen, Fu-Ming
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (07): : 1810 - 1821
  • [9] miR-34a: A Promising Target for Inflammaging and Age-Related Diseases
    Raucci, Angela
    Vinci, Maria Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21)
  • [10] Autophagy in Metabolic Age-Related Human Diseases
    Moulis, Manon
    Vindis, Cecile
    CELLS, 2018, 7 (10)